EQ vs LIN · rev $41.1M vs P/E 34, rev $33.99B
Equillium Inc (EQ) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
EQ currently screens at market cap $189.0M. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the EQ and LIN stock pages for the full models.
Not investment advice.